Target Volume Determination 2015

Reduces recurrence 31% to 15.4% (N- (7287 pts)) and 63.7% to 42.5% (N+ (1050 pts)) • 10 year gain 15,7% (N-) and 21,2% (N+) Reduces breast cancer mortality of 20.5% to 17.2% (N-) and 51.3% to 42.8% (N+) • 15 year gain 3.3% (N-) and 8.5% (N+)